Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study

Christ, Lisa; Seitz, Luca; Scholz, Godehard; Sarbu, Adela-Cristina; Amsler, Jennifer; Bütikofer, Lukas; Tappeiner, Christoph; Kollert, Florian; Reichenbach, Stephan; Villiger, Peter M. (2021). Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study. The Lancet. Rheumatology, 3(9), e619-e626. Elsevier 10.1016/S2665-9913(21)00152-1

[img] Text
PIIS2665991321001521.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (643kB) | Request a copy

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology
04 Faculty of Medicine > Pre-clinic Human Medicine > CTU Bern
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Christ, Lisa Alexandra; Seitz, Luca; Scholz, Godehard Albert; Sarbu, Adela-Cristina; Amsler, Jennifer Susann; Bütikofer, Lukas; Tappeiner, Christoph; Kollert, Florian Kim; Reichenbach, Stephan and Villiger, Peter

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2665-9913

Publisher:

Elsevier

Language:

English

Submitter:

Brigitte Isenschmid

Date Deposited:

22 Nov 2021 11:47

Last Modified:

29 Nov 2021 11:35

Publisher DOI:

10.1016/S2665-9913(21)00152-1

BORIS DOI:

10.48350/161408

URI:

https://boris.unibe.ch/id/eprint/161408

Actions (login required)

Edit item Edit item
Provide Feedback